Press On to Fund Breakthrough Vaccine Trial for Neuroblastoma
Posted on November 18, 2018 by Sarah Turner Davis
Press On is donating $300,000– in two annual installments of $150,000– toward a clinical trial led by Memorial Sloan Kettering Cancer Center (MSK) evaluating a promising new vaccine to counter neuroblastoma. This gift has been matched by The Band of Parents, a group of parents and friends of children with the rare pediatric nervous system cancer.
Until recently, only a small percentage of children with advanced neuroblastoma lived two years past a second remission, but with the vaccine clinicians have seen a high percentage of patients respond well. These results prompted the MSK team to investigate whether vaccinating earlier builds a child’s immunity and improves outcomes even more dramatically.
We can’t wait to see what this research has in store!